Future Microbiology

Papers
(The H4-Index of Future Microbiology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
Pathogenesis, Clinical Manifestations and Complications of COVID-1975
Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long Coronavirus Disease: A Survey of 510 Children69
Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long Covid68
Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis47
Quorum-Sensing Regulation of Virulence Factors in Bacterial Biofilm38
Matrix-Assisted Laser Desorption/ionization Time-Of-Flight Mass Spectrometry: An Emerging Tool for Studying the Vectors of Human Infectious Diseases37
Rezafungin: A Novel Antifungal for the Treatment of Invasive Candidiasis37
Systemic Mycoses: A Potential Alert for Complications in COVID-19 Patients35
Existing Antiviral Options Against SARS-CoV-2 Replication in COVID-19 Patients32
Review of the Use of Nasal and Oral Antiseptics During a Global Pandemic30
Covid-19: It's All About Sepsis30
Drug Repurposing Against SARS-CoV-1, SARS-CoV-2 and MERS-CoV30
The Interplay of SARS-CoV-2 and Clostridioides Difficile Infection25
Phages in the Fight Against COVID-19?25
Pathogenic Arsenal of Pseudomonas Aeruginosa : An Update on Virulence Factors23
Dual Targeting of Toll-Like Receptor 4 and Angiotensin-Converting Enzyme 2: A proposed Approach to SARS-CoV-2 Treatment21
Diagnosis of Osteoarticular Tuberculosis: Multi-Targeted Loop-Mediated Isothermal Amplification Assay Versus Multiplex PCR20
Covid-19: Mask Efficacy is Dependent on Both Fabric and Fit20
Mutation Profile of Over 4500 SARS-CoV-2 Isolations Reveals Prevalent Cytosine-to-Uridine Deamination on Viral RNAs19
Vaginal Microbiome: Considerations For Reproductive Health19
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients19
Treatment of Severe Infections Due to Metallo-β-Lactamases-Producing Gram-Negative Bacteria19
0.083364009857178